Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice

Journal of Clinical Investigation

Volumn 121, Issue 10, 2011, Pages 3924-3931

  Krohn, Markus ^a   Lange, Cathleen ^a   Hofrichter, Jacqueline ^a   Scheffler, Katja ^a   Stenzel, Jan ^a   Steffen, Johannes ^a   Schumacher, Toni ^a   Brüning, Thomas ^a   Plath, Anne Sophie ^a   Alfen, Franziska ^a   Schmidt, Anke ^a   Winter, Felix ^a   Rateitschak, Katja ^a   Wree, Andreas ^a   Gsponer, Jörg ^b   Walker, Lary C ^c   Pahnke, Jens ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MEMBRANE PROTEIN; PROTEIN ABCC1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN TRANSPORT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MICROVESSELS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN MULTIMERIZATION;

EID: 80053387416     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57867     Document Type: Article

References (40)

1. Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science. 2008;319(5865):916-919. (Pubitemid 351263754)
2. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron. 2001;32(2):177-180. (Pubitemid 33030186)
3. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010;362(4):329-344.
4. Mawuenyega KG, et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science. 2010;330(6012):1774.
5. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010;13(7):805-811.
6. Lipinski MM, et al. Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc Natl Acad Sci U S A. 2010;107(32):14164-14169.
7. Deane R, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. 2003;9(7):907-913. (Pubitemid 36889934)
8. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 2008;18(2):253-266. (Pubitemid 351430402)
9. Pahnke J, Walker LC, Scheffler K, Krohn M. Alzheimer's disease and blood-brain barrier function-Why have anti-beta-amyloid therapies failed to prevent dementia progression? Neurosci Biobehav Rev. 2009;33(7):1099-1108.
10. Deane R, Wu Z, Zlokovic BV. RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke. 2004;35(11 suppl 1):2628-2631. (Pubitemid 39458354)
11. Shibata M, et al. Clearance of Alzheimer's amyloidss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000;106(12):1489-1499. (Pubitemid 32038587)
12. Kuhnke D, et al. MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier. Brain Pathol. 2007;17(4):347-353. (Pubitemid 47537591)
13. Lam FC, et al. beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem. 2001;76(4):1121-1128.
14. Hartz AM, Miller DS, Bauer B. Restoring bloodbrain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol. 2010;77(5):715-723.
15. Vogelgesang S, et al. The role of P-glycoprotein in cerebral amyloid angiopathy; implications for the early pathogenesis of Alzheimer's disease. Curr Alzheimer Res. 2004;1(2):121-125.
16. Xiong H, et al. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta (1-40) peptides. J Neurosci. 2009;29(17):5463-5475.
17. Cirrito JR, et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest. 2005;115(11):3285-3290. (Pubitemid 41567593)
18. Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280(52):43224-43235. (Pubitemid 43049289)
19. Pahnke J, Wolkenhauer O, Krohn M, Walker LC. Clinico-pathologic function of cerebral ABC transporters - implications for the pathogenesis of Alzheimer's disease. Curr Alzheimer Res. 2008;5(4):396-405.
20. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 2008;9(1):105-127. (Pubitemid 351560534)
21. Burgold S, et al. In vivo multiphoton imaging reveals gradual growth of newborn amyloid plaques over weeks. Acta Neuropathol. 2011;121(3):327-335.
22. Radde R, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7(9):940-946. (Pubitemid 44523975)
23. Scheffler K, et al. Determination of spatial and temporal distribution of microglia by 230nm-high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer's disease [published online ahead of print January 19, 2011]. Curr Alzheimer Res. PMID: 21244350.
24. Wijnholds J, et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat Med. 1997;3(11):1275-1279. (Pubitemid 27508831)
25. Levy E, Prelli F, Frangione B. Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant. J Alzheimers Dis. 2006;9(3 suppl):329-339. (Pubitemid 44253327)
26. Monro OR, et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging. 2002;23(3):405-412. (Pubitemid 34312024)
27. Wesołowska O, Molnar J, Ocsovszki I, Michalak K. Differential effect of phenothiazines on MRP1 and P-glycoprotein activity. In Vivo. 2009;23(6):943-947.
28. Rao VV, et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci U S A. 1999;96(7):3900-3905. (Pubitemid 29169008)
29. Wijnholds J, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest. 2000;105(3):279-285. (Pubitemid 30094447)
30. Serot JM, Bene MC, Faure GC. Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci. 2003;8:s515-s521. (Pubitemid 39140178)
31. Bartels AL, van Berckel BN, Lubberink M, Luurtsema G, Lammertsma AA, Leenders KL. Blood-brain barrier P-glycoprotein function is not impaired in early Parkinson's disease. Parkinsonism Relat Disord. 2008;14(6):505-508.
32. Volk HA, Burkhardt K, Potschka H, Chen J, Becker A, Loscher W. Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures. NeuroScience. 2004;123(3):751-759. (Pubitemid 38045412)
33. Lee CH. Reversing agents for ATP-binding cassette drug transporters. Methods Mol Biol. 2010;596:325-340.
34. Herzig MC, et al. Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci. 2004;7(9):954-960. (Pubitemid 39129504)
35. Jonker JW, et al. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci U S A. 2002;99(24):15649-15654. (Pubitemid 35403986)
36. Schinkel AH, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994;77(4):491-502. (Pubitemid 24153990)
37. Lesné S, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440(7082):352-357.
38. Cox B, Emili A. Tissue subcellular fractionation and protein extraction for use in mass-spectrometry-based proteomics. Nat Protoc. 2006;1(4):1872-1878. (Pubitemid 46778056)
39. Coisne C, et al. Mouse syngenic in vitro bloodbrain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab Invest. 2005;85(6):734-746. (Pubitemid 40799703)
40. Siflinger-Birnboim A, Cooper JA, Del Vecchio PJ, Lum H, Malik AB. Selectivity of the endothelial monolayer: effects of increased permeability. Microvasc Res. 1988;36(3):216-227. (Pubitemid 19000558)